The global Pets Anti Infective Medicine market is projected to grow from US$ 1804 million in 2024 to US$ 2559 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.

Pets Anti Infective Medicine Market

Anti-infective medicines for pets are medications used to treat and prevent infections in animals.

These medications kill or inhibit the growth of bacteria. Common types of antibiotics for pets include penicillins, cephalosporins, tetracyclines, and fluoroquinolones.These medications are used to treat viral infections in pets. Examples include acyclovir, famciclovir, and interferon.

These medicines are used to treat and prevent parasites in pets, including fleas, ticks, mites, and worms. Some common antiparasitic medications include ivermectin, milbemycin, fenbendazole, and praziquantel.

Report Covers:

This report presents an overview of global market for Pets Anti Infective Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pets Anti Infective Medicine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pets Anti Infective Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pets Anti Infective Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pets Anti Infective Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pets Anti Infective Medicine sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pets Anti Infective Medicine Market Report

Report Metric	Details
Report Name	Pets Anti Infective Medicine Market
Accounted market size in 2024	US$ 1804 million
Forecasted market size in 2030	US$ 2559 million
CAGR	6.0
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	External Use Internal Use
Segment by Application	Dogs Cats Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pets Anti Infective Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pets Anti Infective Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pets Anti Infective Medicine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Pets Anti Infective Medicine Market growing?

Ans: The Pets Anti Infective Medicine Market witnessing a CAGR of 6.0 during the forecast period 2025-2030.

What is the Pets Anti Infective Medicine Market size in 2030?

Ans: The Pets Anti Infective Medicine Market size in 2030 will be US$ 2559 million.

Who are the main players in the Pets Anti Infective Medicine Market report?

Ans: The main players in the Pets Anti Infective Medicine Market are Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Chanelle

What are the Application segmentation covered in the Pets Anti Infective Medicine Market report?

Ans: The Applications covered in the Pets Anti Infective Medicine Market report are Dogs, Cats, Other

What are the Type segmentation covered in the Pets Anti Infective Medicine Market report?

Ans: The Types covered in the Pets Anti Infective Medicine Market report are External Use, Internal Use

1 Study Coverage

1.1 Pets Anti Infective Medicine Product Introduction

1.2 Market by Type

1.2.1 Global Pets Anti Infective Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 External Use

1.2.3 Internal Use

1.3 Market by Application

1.3.1 Global Pets Anti Infective Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Dogs

1.3.3 Cats

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pets Anti Infective Medicine Sales Estimates and Forecasts 2019-2030

2.2 Global Pets Anti Infective Medicine Revenue by Region

2.2.1 Global Pets Anti Infective Medicine Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Pets Anti Infective Medicine Revenue by Region (2019-2024)

2.2.3 Global Pets Anti Infective Medicine Revenue by Region (2025-2030)

2.2.4 Global Pets Anti Infective Medicine Revenue Market Share by Region (2019-2030)

2.3 Global Pets Anti Infective Medicine Sales Estimates and Forecasts 2019-2030

2.4 Global Pets Anti Infective Medicine Sales by Region

2.4.1 Global Pets Anti Infective Medicine Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Pets Anti Infective Medicine Sales by Region (2019-2024)

2.4.3 Global Pets Anti Infective Medicine Sales by Region (2025-2030)

2.4.4 Global Pets Anti Infective Medicine Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Pets Anti Infective Medicine Sales by Manufacturers

3.1.1 Global Pets Anti Infective Medicine Sales by Manufacturers (2019-2024)

3.1.2 Global Pets Anti Infective Medicine Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pets Anti Infective Medicine in 2023

3.2 Global Pets Anti Infective Medicine Revenue by Manufacturers

3.2.1 Global Pets Anti Infective Medicine Revenue by Manufacturers (2019-2024)

3.2.2 Global Pets Anti Infective Medicine Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Pets Anti Infective Medicine Revenue in 2023

3.3 Global Key Players of Pets Anti Infective Medicine, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Pets Anti Infective Medicine Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Pets Anti Infective Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Pets Anti Infective Medicine, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Pets Anti Infective Medicine, Product Offered and Application

3.8 Global Key Manufacturers of Pets Anti Infective Medicine, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Pets Anti Infective Medicine Sales by Type

4.1.1 Global Pets Anti Infective Medicine Historical Sales by Type (2019-2024)

4.1.2 Global Pets Anti Infective Medicine Forecasted Sales by Type (2025-2030)

4.1.3 Global Pets Anti Infective Medicine Sales Market Share by Type (2019-2030)

4.2 Global Pets Anti Infective Medicine Revenue by Type

4.2.1 Global Pets Anti Infective Medicine Historical Revenue by Type (2019-2024)

4.2.2 Global Pets Anti Infective Medicine Forecasted Revenue by Type (2025-2030)

4.2.3 Global Pets Anti Infective Medicine Revenue Market Share by Type (2019-2030)

4.3 Global Pets Anti Infective Medicine Price by Type

4.3.1 Global Pets Anti Infective Medicine Price by Type (2019-2024)

4.3.2 Global Pets Anti Infective Medicine Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Pets Anti Infective Medicine Sales by Application

5.1.1 Global Pets Anti Infective Medicine Historical Sales by Application (2019-2024)

5.1.2 Global Pets Anti Infective Medicine Forecasted Sales by Application (2025-2030)

5.1.3 Global Pets Anti Infective Medicine Sales Market Share by Application (2019-2030)

5.2 Global Pets Anti Infective Medicine Revenue by Application

5.2.1 Global Pets Anti Infective Medicine Historical Revenue by Application (2019-2024)

5.2.2 Global Pets Anti Infective Medicine Forecasted Revenue by Application (2025-2030)

5.2.3 Global Pets Anti Infective Medicine Revenue Market Share by Application (2019-2030)

5.3 Global Pets Anti Infective Medicine Price by Application

5.3.1 Global Pets Anti Infective Medicine Price by Application (2019-2024)

5.3.2 Global Pets Anti Infective Medicine Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Pets Anti Infective Medicine Market Size by Type

6.1.1 US & Canada Pets Anti Infective Medicine Sales by Type (2019-2030)

6.1.2 US & Canada Pets Anti Infective Medicine Revenue by Type (2019-2030)

6.2 US & Canada Pets Anti Infective Medicine Market Size by Application

6.2.1 US & Canada Pets Anti Infective Medicine Sales by Application (2019-2030)

6.2.2 US & Canada Pets Anti Infective Medicine Revenue by Application (2019-2030)

6.3 US & Canada Pets Anti Infective Medicine Market Size by Country

6.3.1 US & Canada Pets Anti Infective Medicine Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Pets Anti Infective Medicine Sales by Country (2019-2030)

6.3.3 US & Canada Pets Anti Infective Medicine Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Pets Anti Infective Medicine Market Size by Type

7.1.1 Europe Pets Anti Infective Medicine Sales by Type (2019-2030)

7.1.2 Europe Pets Anti Infective Medicine Revenue by Type (2019-2030)

7.2 Europe Pets Anti Infective Medicine Market Size by Application

7.2.1 Europe Pets Anti Infective Medicine Sales by Application (2019-2030)

7.2.2 Europe Pets Anti Infective Medicine Revenue by Application (2019-2030)

7.3 Europe Pets Anti Infective Medicine Market Size by Country

7.3.1 Europe Pets Anti Infective Medicine Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Pets Anti Infective Medicine Sales by Country (2019-2030)

7.3.3 Europe Pets Anti Infective Medicine Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Pets Anti Infective Medicine Market Size

8.1.1 China Pets Anti Infective Medicine Sales (2019-2030)

8.1.2 China Pets Anti Infective Medicine Revenue (2019-2030)

8.2 China Pets Anti Infective Medicine Market Size by Application

8.2.1 China Pets Anti Infective Medicine Sales by Application (2019-2030)

8.2.2 China Pets Anti Infective Medicine Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Pets Anti Infective Medicine Market Size by Type

9.1.1 Asia Pets Anti Infective Medicine Sales by Type (2019-2030)

9.1.2 Asia Pets Anti Infective Medicine Revenue by Type (2019-2030)

9.2 Asia Pets Anti Infective Medicine Market Size by Application

9.2.1 Asia Pets Anti Infective Medicine Sales by Application (2019-2030)

9.2.2 Asia Pets Anti Infective Medicine Revenue by Application (2019-2030)

9.3 Asia Pets Anti Infective Medicine Sales by Region

9.3.1 Asia Pets Anti Infective Medicine Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Pets Anti Infective Medicine Revenue by Region (2019-2030)

9.3.3 Asia Pets Anti Infective Medicine Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Pets Anti Infective Medicine Market Size by Type

10.1.1 Middle East, Africa and Latin America Pets Anti Infective Medicine Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Pets Anti Infective Medicine Market Size by Application

10.2.1 Middle East, Africa and Latin America Pets Anti Infective Medicine Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Pets Anti Infective Medicine Sales by Country

10.3.1 Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Pets Anti Infective Medicine Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Boehringer Ingelheim

11.1.1 Boehringer Ingelheim Company Information

11.1.2 Boehringer Ingelheim Overview

11.1.3 Boehringer Ingelheim Pets Anti Infective Medicine Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Boehringer Ingelheim Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Boehringer Ingelheim Recent Developments

11.2 Zoetis

11.2.1 Zoetis Company Information

11.2.2 Zoetis Overview

11.2.3 Zoetis Pets Anti Infective Medicine Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Zoetis Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Zoetis Recent Developments

11.3 Merck

11.3.1 Merck Company Information

11.3.2 Merck Overview

11.3.3 Merck Pets Anti Infective Medicine Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Merck Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Merck Recent Developments

11.4 Elanco

11.4.1 Elanco Company Information

11.4.2 Elanco Overview

11.4.3 Elanco Pets Anti Infective Medicine Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Elanco Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Elanco Recent Developments

11.5 Bayer

11.5.1 Bayer Company Information

11.5.2 Bayer Overview

11.5.3 Bayer Pets Anti Infective Medicine Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Bayer Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Bayer Recent Developments

11.6 Virbac

11.6.1 Virbac Company Information

11.6.2 Virbac Overview

11.6.3 Virbac Pets Anti Infective Medicine Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Virbac Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Virbac Recent Developments

11.7 Ceva Sante Animale

11.7.1 Ceva Sante Animale Company Information

11.7.2 Ceva Sante Animale Overview

11.7.3 Ceva Sante Animale Pets Anti Infective Medicine Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Ceva Sante Animale Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Ceva Sante Animale Recent Developments

11.8 Vetoquinol

11.8.1 Vetoquinol Company Information

11.8.2 Vetoquinol Overview

11.8.3 Vetoquinol Pets Anti Infective Medicine Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Vetoquinol Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Vetoquinol Recent Developments

11.9 Bimeda Animal Health

11.9.1 Bimeda Animal Health Company Information

11.9.2 Bimeda Animal Health Overview

11.9.3 Bimeda Animal Health Pets Anti Infective Medicine Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Bimeda Animal Health Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Bimeda Animal Health Recent Developments

11.10 Chanelle

11.10.1 Chanelle Company Information

11.10.2 Chanelle Overview

11.10.3 Chanelle Pets Anti Infective Medicine Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Chanelle Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Chanelle Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Pets Anti Infective Medicine Industry Chain Analysis

12.2 Pets Anti Infective Medicine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Pets Anti Infective Medicine Production Mode & Process

12.4 Pets Anti Infective Medicine Sales and Marketing

12.4.1 Pets Anti Infective Medicine Sales Channels

12.4.2 Pets Anti Infective Medicine Distributors

12.5 Pets Anti Infective Medicine Customers

13 Market Dynamics

13.1 Pets Anti Infective Medicine Industry Trends

13.2 Pets Anti Infective Medicine Market Drivers

13.3 Pets Anti Infective Medicine Market Challenges

13.4 Pets Anti Infective Medicine Market Restraints

14 Key Findings in The Global Pets Anti Infective Medicine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Pets Anti Infective Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of External Use

Table 3. Major Manufacturers of Internal Use

Table 4. Global Pets Anti Infective Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Pets Anti Infective Medicine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Pets Anti Infective Medicine Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Pets Anti Infective Medicine Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Pets Anti Infective Medicine Revenue Market Share by Region (2019-2024)

Table 9. Global Pets Anti Infective Medicine Revenue Market Share by Region (2025-2030)

Table 10. Global Pets Anti Infective Medicine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Pets Anti Infective Medicine Sales by Region (2019-2024) & (K Units)

Table 12. Global Pets Anti Infective Medicine Sales by Region (2025-2030) & (K Units)

Table 13. Global Pets Anti Infective Medicine Sales Market Share by Region (2019-2024)

Table 14. Global Pets Anti Infective Medicine Sales Market Share by Region (2025-2030)

Table 15. Global Pets Anti Infective Medicine Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Pets Anti Infective Medicine Sales Share by Manufacturers (2019-2024)

Table 17. Global Pets Anti Infective Medicine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Pets Anti Infective Medicine Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Pets Anti Infective Medicine, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Pets Anti Infective Medicine Price by Manufacturers 2019-2024 (USD/Unit)

Table 21. Global Pets Anti Infective Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Pets Anti Infective Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pets Anti Infective Medicine as of 2023)

Table 23. Global Key Manufacturers of Pets Anti Infective Medicine, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Pets Anti Infective Medicine, Product Offered and Application

Table 25. Global Key Manufacturers of Pets Anti Infective Medicine, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Pets Anti Infective Medicine Sales by Type (2019-2024) & (K Units)

Table 28. Global Pets Anti Infective Medicine Sales by Type (2025-2030) & (K Units)

Table 29. Global Pets Anti Infective Medicine Sales Share by Type (2019-2024)

Table 30. Global Pets Anti Infective Medicine Sales Share by Type (2025-2030)

Table 31. Global Pets Anti Infective Medicine Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Pets Anti Infective Medicine Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Pets Anti Infective Medicine Revenue Share by Type (2019-2024)

Table 34. Global Pets Anti Infective Medicine Revenue Share by Type (2025-2030)

Table 35. Pets Anti Infective Medicine Price by Type (2019-2024) & (USD/Unit)

Table 36. Global Pets Anti Infective Medicine Price Forecast by Type (2025-2030) & (USD/Unit)

Table 37. Global Pets Anti Infective Medicine Sales by Application (2019-2024) & (K Units)

Table 38. Global Pets Anti Infective Medicine Sales by Application (2025-2030) & (K Units)

Table 39. Global Pets Anti Infective Medicine Sales Share by Application (2019-2024)

Table 40. Global Pets Anti Infective Medicine Sales Share by Application (2025-2030)

Table 41. Global Pets Anti Infective Medicine Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Pets Anti Infective Medicine Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Pets Anti Infective Medicine Revenue Share by Application (2019-2024)

Table 44. Global Pets Anti Infective Medicine Revenue Share by Application (2025-2030)

Table 45. Pets Anti Infective Medicine Price by Application (2019-2024) & (USD/Unit)

Table 46. Global Pets Anti Infective Medicine Price Forecast by Application (2025-2030) & (USD/Unit)

Table 47. US & Canada Pets Anti Infective Medicine Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Pets Anti Infective Medicine Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Pets Anti Infective Medicine Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Pets Anti Infective Medicine Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Pets Anti Infective Medicine Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Pets Anti Infective Medicine Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Pets Anti Infective Medicine Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Pets Anti Infective Medicine Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Pets Anti Infective Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Pets Anti Infective Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Pets Anti Infective Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Pets Anti Infective Medicine Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Pets Anti Infective Medicine Sales by Country (2025-2030) & (K Units)

Table 60. Europe Pets Anti Infective Medicine Sales by Type (2019-2024) & (K Units)

Table 61. Europe Pets Anti Infective Medicine Sales by Type (2025-2030) & (K Units)

Table 62. Europe Pets Anti Infective Medicine Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Pets Anti Infective Medicine Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Pets Anti Infective Medicine Sales by Application (2019-2024) & (K Units)

Table 65. Europe Pets Anti Infective Medicine Sales by Application (2025-2030) & (K Units)

Table 66. Europe Pets Anti Infective Medicine Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Pets Anti Infective Medicine Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Pets Anti Infective Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Pets Anti Infective Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Pets Anti Infective Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Pets Anti Infective Medicine Sales by Country (2019-2024) & (K Units)

Table 72. Europe Pets Anti Infective Medicine Sales by Country (2025-2030) & (K Units)

Table 73. China Pets Anti Infective Medicine Sales by Type (2019-2024) & (K Units)

Table 74. China Pets Anti Infective Medicine Sales by Type (2025-2030) & (K Units)

Table 75. China Pets Anti Infective Medicine Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Pets Anti Infective Medicine Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Pets Anti Infective Medicine Sales by Application (2019-2024) & (K Units)

Table 78. China Pets Anti Infective Medicine Sales by Application (2025-2030) & (K Units)

Table 79. China Pets Anti Infective Medicine Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Pets Anti Infective Medicine Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Pets Anti Infective Medicine Sales by Type (2019-2024) & (K Units)

Table 82. Asia Pets Anti Infective Medicine Sales by Type (2025-2030) & (K Units)

Table 83. Asia Pets Anti Infective Medicine Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Pets Anti Infective Medicine Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Pets Anti Infective Medicine Sales by Application (2019-2024) & (K Units)

Table 86. Asia Pets Anti Infective Medicine Sales by Application (2025-2030) & (K Units)

Table 87. Asia Pets Anti Infective Medicine Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Pets Anti Infective Medicine Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Pets Anti Infective Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Pets Anti Infective Medicine Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Pets Anti Infective Medicine Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Pets Anti Infective Medicine Sales by Region (2019-2024) & (K Units)

Table 93. Asia Pets Anti Infective Medicine Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Pets Anti Infective Medicine Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Pets Anti Infective Medicine Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Pets Anti Infective Medicine Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Pets Anti Infective Medicine Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Pets Anti Infective Medicine Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Pets Anti Infective Medicine Sales by Country (2025-2030) & (K Units)

Table 107. Boehringer Ingelheim Company Information

Table 108. Boehringer Ingelheim Description and Major Businesses

Table 109. Boehringer Ingelheim Pets Anti Infective Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Boehringer Ingelheim Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Boehringer Ingelheim Recent Developments

Table 112. Zoetis Company Information

Table 113. Zoetis Description and Major Businesses

Table 114. Zoetis Pets Anti Infective Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. Zoetis Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Zoetis Recent Developments

Table 117. Merck Company Information

Table 118. Merck Description and Major Businesses

Table 119. Merck Pets Anti Infective Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. Merck Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Merck Recent Developments

Table 122. Elanco Company Information

Table 123. Elanco Description and Major Businesses

Table 124. Elanco Pets Anti Infective Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 125. Elanco Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Elanco Recent Developments

Table 127. Bayer Company Information

Table 128. Bayer Description and Major Businesses

Table 129. Bayer Pets Anti Infective Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 130. Bayer Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Bayer Recent Developments

Table 132. Virbac Company Information

Table 133. Virbac Description and Major Businesses

Table 134. Virbac Pets Anti Infective Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 135. Virbac Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Virbac Recent Developments

Table 137. Ceva Sante Animale Company Information

Table 138. Ceva Sante Animale Description and Major Businesses

Table 139. Ceva Sante Animale Pets Anti Infective Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 140. Ceva Sante Animale Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Ceva Sante Animale Recent Developments

Table 142. Vetoquinol Company Information

Table 143. Vetoquinol Description and Major Businesses

Table 144. Vetoquinol Pets Anti Infective Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 145. Vetoquinol Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Vetoquinol Recent Developments

Table 147. Bimeda Animal Health Company Information

Table 148. Bimeda Animal Health Description and Major Businesses

Table 149. Bimeda Animal Health Pets Anti Infective Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 150. Bimeda Animal Health Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Bimeda Animal Health Recent Developments

Table 152. Chanelle Company Information

Table 153. Chanelle Description and Major Businesses

Table 154. Chanelle Pets Anti Infective Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 155. Chanelle Pets Anti Infective Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Chanelle Recent Developments

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Pets Anti Infective Medicine Distributors List

Table 160. Pets Anti Infective Medicine Customers List

Table 161. Pets Anti Infective Medicine Market Trends

Table 162. Pets Anti Infective Medicine Market Drivers

Table 163. Pets Anti Infective Medicine Market Challenges

Table 164. Pets Anti Infective Medicine Market Restraints

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

List of Figures

Figure 1. Pets Anti Infective Medicine Product Picture

Figure 2. Global Pets Anti Infective Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pets Anti Infective Medicine Market Share by Type in 2023 & 2030

Figure 4. External Use Product Picture

Figure 5. Internal Use Product Picture

Figure 6. Global Pets Anti Infective Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Pets Anti Infective Medicine Market Share by Application in 2023 & 2030

Figure 8. Dogs

Figure 9. Cats

Figure 10. Other

Figure 11. Pets Anti Infective Medicine Report Years Considered

Figure 12. Global Pets Anti Infective Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Pets Anti Infective Medicine Revenue 2019-2030 (US$ Million)

Figure 14. Global Pets Anti Infective Medicine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Pets Anti Infective Medicine Revenue Market Share by Region (2019-2030)

Figure 16. Global Pets Anti Infective Medicine Sales 2019-2030 ((K Units)

Figure 17. Global Pets Anti Infective Medicine Sales Market Share by Region (2019-2030)

Figure 18. US & Canada Pets Anti Infective Medicine Sales YoY (2019-2030) & (K Units)

Figure 19. US & Canada Pets Anti Infective Medicine Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Pets Anti Infective Medicine Sales YoY (2019-2030) & (K Units)

Figure 21. Europe Pets Anti Infective Medicine Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Pets Anti Infective Medicine Sales YoY (2019-2030) & (K Units)

Figure 23. China Pets Anti Infective Medicine Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Asia (excluding China) Pets Anti Infective Medicine Sales YoY (2019-2030) & (K Units)

Figure 25. Asia (excluding China) Pets Anti Infective Medicine Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Pets Anti Infective Medicine Sales YoY (2019-2030) & (K Units)

Figure 27. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue YoY (2019-2030) & (US$ Million)

Figure 28. The Pets Anti Infective Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 29. The Top 5 and 10 Largest Manufacturers of Pets Anti Infective Medicine in the World: Market Share by Pets Anti Infective Medicine Revenue in 2023

Figure 30. Global Pets Anti Infective Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 31. Global Pets Anti Infective Medicine Sales Market Share by Type (2019-2030)

Figure 32. Global Pets Anti Infective Medicine Revenue Market Share by Type (2019-2030)

Figure 33. Global Pets Anti Infective Medicine Sales Market Share by Application (2019-2030)

Figure 34. Global Pets Anti Infective Medicine Revenue Market Share by Application (2019-2030)

Figure 35. US & Canada Pets Anti Infective Medicine Sales Market Share by Type (2019-2030)

Figure 36. US & Canada Pets Anti Infective Medicine Revenue Market Share by Type (2019-2030)

Figure 37. US & Canada Pets Anti Infective Medicine Sales Market Share by Application (2019-2030)

Figure 38. US & Canada Pets Anti Infective Medicine Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Pets Anti Infective Medicine Revenue Share by Country (2019-2030)

Figure 40. US & Canada Pets Anti Infective Medicine Sales Share by Country (2019-2030)

Figure 41. U.S. Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 42. Canada Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 43. Europe Pets Anti Infective Medicine Sales Market Share by Type (2019-2030)

Figure 44. Europe Pets Anti Infective Medicine Revenue Market Share by Type (2019-2030)

Figure 45. Europe Pets Anti Infective Medicine Sales Market Share by Application (2019-2030)

Figure 46. Europe Pets Anti Infective Medicine Revenue Market Share by Application (2019-2030)

Figure 47. Europe Pets Anti Infective Medicine Revenue Share by Country (2019-2030)

Figure 48. Europe Pets Anti Infective Medicine Sales Share by Country (2019-2030)

Figure 49. Germany Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 50. France Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 51. U.K. Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 52. Italy Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 53. Russia Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 54. China Pets Anti Infective Medicine Sales Market Share by Type (2019-2030)

Figure 55. China Pets Anti Infective Medicine Revenue Market Share by Type (2019-2030)

Figure 56. China Pets Anti Infective Medicine Sales Market Share by Application (2019-2030)

Figure 57. China Pets Anti Infective Medicine Revenue Market Share by Application (2019-2030)

Figure 58. Asia Pets Anti Infective Medicine Sales Market Share by Type (2019-2030)

Figure 59. Asia Pets Anti Infective Medicine Revenue Market Share by Type (2019-2030)

Figure 60. Asia Pets Anti Infective Medicine Sales Market Share by Application (2019-2030)

Figure 61. Asia Pets Anti Infective Medicine Revenue Market Share by Application (2019-2030)

Figure 62. Asia Pets Anti Infective Medicine Revenue Share by Region (2019-2030)

Figure 63. Asia Pets Anti Infective Medicine Sales Share by Region (2019-2030)

Figure 64. Japan Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 65. South Korea Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 66. China Taiwan Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 67. Southeast Asia Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 68. India Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 69. Middle East, Africa and Latin America Pets Anti Infective Medicine Sales Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Pets Anti Infective Medicine Sales Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Pets Anti Infective Medicine Revenue Share by Country (2019-2030)

Figure 74. Middle East, Africa and Latin America Pets Anti Infective Medicine Sales Share by Country (2019-2030)

Figure 75. Brazil Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 76. Mexico Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 77. Turkey Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 78. Israel Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 79. GCC Countries Pets Anti Infective Medicine Revenue (2019-2030) & (US$ Million)

Figure 80. Pets Anti Infective Medicine Value Chain

Figure 81. Pets Anti Infective Medicine Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions